Clifford Chance has handled its first no-win no-fee case
The firm was acting for the Multiple Sclerosis Society in its successful campaign to persuade the Government to dispense the controversial MS drug Beta Interferon on the NHS. Clifford Chance took the case on a pro bono basis, but agreed that the CFA could be a productive tactic. This way, the MS Society would not have to pay Clifford Chance if it lost the case, but if it won, the Government would have to pay the costs, estimated at no less than £250,000. The firm worked on the case for two years. However, it did not have the chance to implement the CFA in court. The firm was planning to take it to the High Court when the Government changed its policy and ordered the NHS to pay for the drug.